[1]
Ayesha Erum Hadi, “EXAMINING CD133, C-MYC, AND AXL EXPRESSION IN COLON ADENOCARCINOMAS: PROGNOSTIC VALUE AND CLINICAL ASSOCIATIONS”, J Popl Ther Clin Pharmacol, vol. 31, no. 5, pp. 273–283, May 2024, doi: 10.53555/jptcp.v31i5.6138.